GKOS Stock Analysis: Buy, Sell, or Hold?
GKOS - Glaukos Corporation
$113.64
2.86 (2.58%)
▲
5d:
+3.42%
30d:
-16.35%
90d:
-1.5%
BUY
HIGH Confidence
Analysis Updated: Jun 3, 2026 12:00 AM ET
Earnings: Jul 29, 2026
Get Alerted When GKOS Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
✅ BUY SIGNAL: GKOS appears deeply undervalued. Market expects -4.1% annual earnings decline despite 1896% recent earnings growth. Contrarian opportunity at discount to historical valuation.
✅ BUY SIGNAL: GKOS appears deeply undervalued. Market expects -4.1% annual earnings decline despite 1896% recent earnings growth. Contrarian opportunity at discount to historical valuation.
Long-Term Wealth Forecast (2031)
Based on Analyst Consensus Growth & Historical Valuation
0% (Stagnation)
50% (Hyper Growth)
EST. PRICE IN 2031
$16.79
Based on 7.0% avg growth
INTRINSIC VALUE TODAY
$10.42
Trading above historical range
How this is calculated: We use a Growth Decay Model: starting with analyst consensus growth (adjusted above) and gradually slowing it down to a long-term terminal rate (4%) by Year 5. This provides a more realistic valuation than assuming constant hyper-growth. We then apply a 25.0x Exit PE.
In-depth Analysis How we analyze
Valuation Analysis: GKOS is currently trading at $113.64, which is considered oversold relative to its 30-day fair value range of $115.01 to $141.67. From a valuation perspective, the stock is trading at a discount (Forward PE: 237.2) compared to its historical average (269.1). Remarkably, the market is currently pricing in an annual earnings decline of 4.1% over the next few years. This pessimistic expectation contrasts with the company's recent 1896.3% earnings growth, suggesting potential undervaluation if the company simply maintains stability.
Technical Outlook: Technically, GKOS is in a uptrend. Immediate support is located at $99.48, while resistance sits at $146.71.
Market Sentiment: The stock shows a mixed technical setup (40/100), with neutral trendline and momentum signals. Wall Street analysts see significant upside, with an average price target of $154.50 (+36.0%). Combining these factors, the current setup offers a favorable risk/reward ratio for buyers.
Technical Outlook: Technically, GKOS is in a uptrend. Immediate support is located at $99.48, while resistance sits at $146.71.
Market Sentiment: The stock shows a mixed technical setup (40/100), with neutral trendline and momentum signals. Wall Street analysts see significant upside, with an average price target of $154.50 (+36.0%). Combining these factors, the current setup offers a favorable risk/reward ratio for buyers.
Quick Decision Summary
Current Position
OVERSOLD
Historical Trading Range
$115.01 -
$141.67
Company Quality Score
55/100
(HOLD)
Volume Confirmation
HIGH
Confidence Score
79.5%
All Signals
- BULLISH: Price oversold vs 30-day range
- NEUTRAL: Mixed technical signals (40/100)
- BULLISH: High volume confirmation
- BULLISH: Trading 36.0% below Wall St target ($154.50)
Trading Range Analysis
30-Day Trading Range
$115.01 -
$141.67
Current vs Trading Range
OVERSOLD
Support & Resistance Levels
Support Level
$99.48
Resistance Level
$146.71
Current Trend
Uptrend
Technical data as of
Jun 3, 2026
Fundamental Context
Forward P/E (Next Year Est.)
237.15
Wall Street Target
$154.50
(+36.0%)
Revenue Growth (YoY)
41.2%
Earnings Growth (YoY)
1896.3%
Profit Margin
-34.3%
Valuation Discount vs History
-4.1% cheaper
PE vs Historical
237.2 vs 269.1
CHEAP
Market-Implied Price Targets
If current PE multiple persists
Implied Growth (YoY):
-4.1%
(market-implied from PE analysis)
1-Year Target
$108.98
(-4%)
2-Year Target
$104.51
(-8%)
3-Year Target
$100.23
(-12%)
3-Yr Target (if PE normalizes)
(PE: 237→269)
$113.73
(+0%)
💡
Upside Surprise Potential
If earnings stabilize (0% growth), PE could expand from 237.1 to 269.1
Stabilization Target:
$128.95
(+13.5%)
PE Expansion Potential:
+13.5%
Share & Embed Analysis
Last updated: June 04, 2026 12:42 AM ET
Data refreshes hourly during market hours. Next update: 1:42 AM
Data refreshes hourly during market hours. Next update: 1:42 AM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is GKOS showing a specific setup today?
Insider Activity (6 Months)
0
Buys
10
Sells
Net
INSIDERS SELLING
Recent Transactions
Alex R Thurman
SELL
2511 shares
2026-03-25
Alex R Thurman
SELL
1521 shares
2026-03-24
Alex R Thurman
SELL
625 shares
2026-03-17
Top Rated Medical Devices Stocks
Top-rated stocks in Medical Devices by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
BSX
Boston Scientific Corp |
STRONG BUY
34 analysts |
$83 | 54 HOLD |
|
ABT
Abbott Laboratories |
BUY
28 analysts |
$119 | 64 BUY |
|
SYK
Stryker Corporation |
BUY
32 analysts |
$389 | 49 HOLD |
|
PODD
Insulet Corporation |
STRONG BUY
23 analysts |
$247 | 62 BUY |
|
MDT
Medtronic PLC |
BUY
32 analysts |
$107 | 61 BUY |
Advanced GKOS Option Strategies
Professional options setups generated by AI based on today's GKOS price and gamma walls.
